SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-048656
Filing Date
2021-09-17
Accepted
2021-09-17 17:30:37
Documents
3
Period of Report
2021-09-17

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea147559-6k_cellectbio.htm 6-K 50599
2 AMENDMENT AGREEMENT DATED AS OF SEPTEMBER 17, 2021, BY AND AMONG ea147559ex99-1_cellectbio.htm EX-99.1 414245
3 LETTER AGREEMENT DATED SEPTEMBER 17, 2021, BETWEEN QUOIN PHARMACEUTICALS, INC. A ea147559ex99-2_cellectbio.htm EX-99.2 15043
  Complete submission text file 0001213900-21-048656.txt   480943
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Cellect Biotechnology Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-37846 | Film No.: 211261454
SIC: 3841 Surgical & Medical Instruments & Apparatus